|
⚲
|
| Keyboard |
| Hegde Priti
✚
|
|
|---|---|
| CIK # | 0001880034 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001880034] | |
| 4 | [0001880034] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hegde Priti | |
| Adaptimmune Therapeutics PLC | |
| TCR2 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2024-07-01 | Grant | 1,144,686 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 152,376 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 226,464 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to Purchase Ordinary Shares · derivative
|
2023-07-05 | Grant | 109,746 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2023-07-03 | Grant | 500,000 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 16,800 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 24,968 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Disposed to issuer | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2022-12-15 | Grant | 16,800 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2021-12-09 | Grant | 12,100 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Stock Option (Right to Buy) · derivative
|
2021-08-25 | Grant | 24,968 | $0.00 |